Stocks and Investing Stocks and Investing
Thu, June 8, 2023

Carter Gould Maintained (BIIB) at Buy on, Jun 8th, 2023


Published on 2024-10-28 04:15:53 - WOPRAI, Carter Gould
  Print publication without navigation
Carter Gould of Barclays, Maintained "Biogen Inc." (BIIB) at Buy on, Jun 8th, 2023.

Carter has made no other calls on BIIB in the last 4 months.



There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 3 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $263 on, Tuesday, May 23rd, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $320 on, Thursday, May 4th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $282 on, Wednesday, April 26th, 2023


These are the ratings of the 12 analyists that currently disagree with Carter


  • Brian Skorney of "Baird" Reiterated at Buy and Held Target at $340 on, Wednesday, June 7th, 2023
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $340 on, Friday, June 2nd, 2023
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $360 on, Thursday, June 1st, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Thursday, May 11th, 2023
  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Increased Target to $350 on, Monday, May 1st, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Wednesday, April 26th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $330 on, Wednesday, April 26th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $371 on, Wednesday, April 26th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, April 26th, 2023
  • Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023
Contributing Sources